Protalix BioTherapeutics, Inc. (DE)
IPOProtalix.com
Public · Carmiel, Israel · Founded 1993 · $52.6M raised
- Headquarters
- Carmiel
- Employees
- 51–200
- Founded
- 1993
- Business Model
- B2B
- Website
- protalix.com
- Total Funding
- $52.6M
- Last Round
- $43.7M Growth EquityMar 2020
- Rounds
- 3
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Biopharmaceutical company developing recombinant therapeutic proteins using proprietary plant cell-based expression system for rare diseases.
Summary
Protalix BioTherapeutics, Inc. (DE) is a Biotech company based in Carmiel, Israel, founded in 1993. It has raised $52.6M in total across 3 rounds, most recently a $43.7M Growth Equity round in Mar 2020. Investors include Pontifax.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Mar 2020
Sign up to see all 4 events
Funding: Venture Round through Growth Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/protalix-biotherapeutics-inc-de"><img src="https://indexed.vc/api/badge/company/protalix-biotherapeutics-inc-de" alt="Protalix BioTherapeutics, Inc. (DE) on Indexed.vc" width="260" height="76" /></a>